Skip to content

Drug interactions

Carbamazepine + Cobimetinib

Severity: Major

Carbamazepine and Cobimetinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Carbamazepine strongly induces CYP3A4 and is expected to markedly reduce cobimetinib exposure, compromising anticancer efficacy. Cobimetinib is a sensitive CYP3A substrate.

What this interaction means in plain words

Carbamazepine and Cobimetinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Carbamazepine belongs to Central Nervous System; Cobimetinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Carbamazepine induces CYP3A4, increasing cobimetinib clearance.

What to do

Avoid concurrent use and choose a non-inducing anticonvulsant. If unavoidable, discuss with oncology, as no validated dose increase exists.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Carbamazepine and Cobimetinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Carbamazepine with Cobimetinib?

MediHelp rates the interaction as major. Carbamazepine and Cobimetinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Carbamazepine strongly induces CYP3A4 and is expected to markedly reduce cobimetinib exposure, compromising anticancer efficacy. Cobimetinib is a sensitive CYP3A substrate.

How serious is the interaction between Carbamazepine and Cobimetinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use and choose a non-inducing anticonvulsant. If unavoidable, discuss with oncology, as no validated dose increase exists.

What other medicines interact with Carbamazepine?

MediHelp also lists interactions of Carbamazepine with, for example, Artemether / lumefantrine, Cabotegravir, Delamanid. The full list is on the Carbamazepine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in